Applied Therapeutics, Inc. (APLT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -18.4M | -20.34M | -28.64M | -19.47M | -23.33M | -22.59M | -18.91M | -17M | -14.73M | -16.45M | -6.99M | -15.89M | -19.39M | -18.4M | -24.41M | -26.94M | -15.66M | -25.91M | -22.21M | -22.75M |
| Operating CF Margin % | -1840.1% | - | - | - | -19122.95% | -15690.97% | -9953.16% | 2549.48% | - | - | -65.57% | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 21.13% | 9.98% | -51.43% | -14.49% | -58.43% | -37.34% | -170.54% | -7% | 24.05% | 10.59% | 71.36% | 41.01% | -23.78% | 28.98% | -9.89% | -18.43% | 24.3% | -62.83% | -17.81% | -83.36% |
| Net Income | -18.99M | -21.33M | -21.82M | 44.01M | -68.59M | 2.9M | -83.94M | -37.68M | -42.37M | -29.58M | -10.14M | -14.43M | -19.1M | -25.86M | -23.12M | -27.16M | -28.42M | -25.83M | -24.18M | -23.69M |
| Depreciation & Amortization | 111K | 110K | 104K | 80K | 104K | 122K | 120K | 6K | 118K | 116K | 114K | 114K | 111K | 110K | 108K | 107K | 105K | 104K | 100K | 99K |
| Stock-Based Compensation | 1.14M | 2.1M | 1.49M | 7.11M | 2.09M | 1.89M | 2.38M | 1.63M | 1.84M | 1.84M | 2.06M | 2M | 3.3M | 2.23M | 2.08M | 2.85M | 2.65M | 2.7M | 2.98M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -41.8M | 27.66M | 14.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.27M | -1.53M | -3.2M | -76.15M | 40.08M | -22.69M | 63.66M | 59.14M | -121K | -884K | 180K | -3.59M | 194K | 5.18M | 1.43M | -105K | 1.02M | 1.95M | -97K | 5.01M |
| Working Capital Changes | -2.93M | 314K | -5.2M | 5.49M | 2.99M | -4.81M | -1.14M | 1.7M | -1.85M | -2.09M | 798K | 11K | -3.89M | -62K | -4.9M | -2.63M | 8.99M | -4.83M | -1.02M | -4.17M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -135K | -7K | 435K | 1.6M | 154K | 414K | 527K | -4.26M | 1.32M | -868K | 1.02M | -2.44M | -1.72M | 2.77M | -3.54M | 291K | 5.86M | -165K | 2.83M | -1.3M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.87M | -6.91M | 5.02M | 5.53M | 9.53M | 11.81M | 8.52M | 16.78M | -24.67M | 28.44M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -75K | 0 | 0 | 0 | 0 | -1.69M | 115.5M | 29.45M | 16.57M | 29.15M | -622K | -933K | -971K | 30.39M | -789K | -1.18M | -1.08M | 3.5M | 73.49M | 3.09M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | -311K | -465K | -465K | -306K | -622K | -933K | -932K | -619K | -789K | -1.18M | -1.18M | -1.28M | -1.07M | -1.07M |
| Equity Issued (Net) | -1K | 0 | 0 | 0 | 0 | -1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | -88K | 1000K | 0 | 1K | 0 | -4K | 1000K | -54K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -74K | 0 | 0 | 0 | 0 | 310K | 9.06M | 3K | 10.32M | 1.57M | 0 | 0 | 49K | 3.1M | 0 | -1K | 104K | 4.78M | 136K | 4.22M |
| Net Change in Cash | -18.48M | -20.34M | -28.64M | -19.47M | -23.33M | -24.29M | 96.59M | 12.44M | 1.84M | 12.7M | 6.26M | -23.73M | -15.34M | 17.51M | -15.67M | -16.32M | -8.23M | -5.63M | 26.6M | 8.79M |
| Free Cash Flow | -18.4M | -20.34M | -28.64M | -19.47M | -23.33M | -22.59M | -18.91M | -17M | -14.73M | -16.45M | -6.99M | -15.89M | -19.39M | -18.4M | -24.41M | -26.94M | -15.66M | -25.91M | -22.21M | -22.75M |
| FCF Margin % | -1840.1% | - | - | - | -19122.95% | -15690.97% | -9953.16% | 2549.48% | - | - | -65.57% | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 21.13% | 9.98% | -51.43% | -14.49% | -58.43% | -37.34% | -170.54% | -7% | 24.05% | 10.59% | 71.36% | 41.01% | -23.78% | 28.98% | -9.89% | -18.43% | 24.3% | -62.83% | -17.81% | -83.36% |
| FCF per Share | -0.13 | -0.14 | -0.20 | -0.14 | -0.16 | -0.16 | -0.15 | -0.20 | -0.16 | -0.21 | -0.12 | -0.32 | -0.40 | -0.68 | -0.93 | -1.03 | -0.60 | -0.99 | -0.92 | -0.94 |
| FCF Conversion (FCF/Net Income) | 0.97x | 0.95x | 1.31x | -0.44x | 0.34x | -7.80x | 0.23x | 0.45x | 0.35x | 0.56x | 0.69x | 1.10x | 1.02x | 0.71x | 1.06x | 0.99x | 0.55x | 1.00x | 0.92x | 0.96x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |